PRWCX · T. Rowe Price Capital Appreciation

185 holdings · expense ratio 0.72% · top 10 = 41.0% · concentration score 41.3/100 · holdings as of 2026-06-30 · SEC N-PORT data (~60-day lag)

Top 25 holdings

#HoldingWeight
1UST15.31%
276105Y4.49%
3AMZN3.33%
4MSFT3.28%
5NVDA2.69%
6GOOGL2.57%
7AVGO2.52%
8CNP2.51%
9META2.48%
10AMD1.83%
11RVTY1.80%
12COR1.78%
13AAPL1.63%
14AUR1.57%
15GOOG1.55%
16MA1.49%
178936471.45%
1844332P1.44%
19TW00023300081.42%
2077958B4021.40%
21DK00606157551.27%
2203827FBD21.21%
23NI1.19%
24AEE1.15%
2544332EAZ91.14%

Sector split

Unclassified
23.4%
Information Technology
17.5%
Treasuries
15.3%
Health Care
10.0%
Utilities
7.5%
Communication Services
6.7%
Consumer Discretionary
5.5%
Cash & Other
5.3%
Financials
4.0%
Industrials
2.6%
Consumer Staples
0.7%
Corporate — industrial & other
0.6%

What has changed

Between March 2026 and June 2026, from 2 months on record:

March 2026June 2026Change
Largest holdingUST18.2%UST15.3%−2.9pp
Top 10 holdings46.0%41.0%−5.0pp
Positions published151185+34

One point per month, taken from the issuer's published holdings file. Tracking began March 2026 — figures from before then were not retained.

Overlaps most with

VBIAX · 35%AGTHX · 28%RGAGX · 28%SCHG · 27%FXAIX · 27%VV · 27%

Share of each fund held in common, by weight, after looking through both.

How much of PRWCX do you already own elsewhere?

If you hold PRWCX alongside other funds, some of these 185 positions are in your portfolio more than once. Paste your holdings to see the real exposure, the duplication, and your own Effective Funds number. Free, no account, nothing stored.

X-ray my portfolio — free →

Watch PRWCX

We re-read PRWCX’s published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.

Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.

Holdings from SEC N-PORT filings, as of 2026-06-30. Weights are fractions of the fund. Check it against its SEC filings. Diagnostics, not advice — x-ray your whole portfolio.